Clariane SE (LON:0OPS)
London · Delayed Price · Currency is GBP · Price in EUR 4.608
+0.169 (3.80%)
At close: Oct 8, 2025
Clariane SE Market Cap
Clariane SE has a market cap or net worth of 1.41 billion as of October 15, 2025. Its market cap has increased by 179.70% in one year.
Market Cap
1.41B
Enterprise Value
8.17B
Revenue
4.55B
Ranking
n/a
PE Ratio
n/a
Stock Price
4.61
Market Cap Chart
Since November 24, 2006, Clariane SE's market cap has increased from 527.71M to 1.41B, an increase of 167.45%. That is a compound annual growth rate of 5.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 1.41B | 129.64% |
| Dec 31, 2024 | 614.59M | 175.90% |
| Dec 29, 2023 | 222.76M | -76.49% |
| Dec 30, 2022 | 947.41M | -61.61% |
| Dec 31, 2021 | 2.47B | -16.31% |
| Dec 31, 2020 | 2.95B | 0.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 197.31B |
| GSK plc | 65.48B |
| Haleon | 30.47B |
| Smith & Nephew | 11.22B |
| ConvaTec Group | 4.82B |
| Hikma Pharmaceuticals | 3.99B |
| HUTCHMED (China) | 1.99B |
| Genus | 1.70B |